Doxorubicin-induced suppression of poly(ADP-ribose) polymerase-1 (PARP-1) activity and expression and its implication for PARP inhibitors in clinical trials.
- DOI
- 10.1007/s00280-010-1359-0
- Published
- 2010-05-21
- Container
- Cancer Chemother Pharmacol
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s00280-010-1359-0,
title = {Doxorubicin-induced suppression of poly(ADP-ribose) polymerase-1 (PARP-1) activity and expression and its implication for PARP inhibitors in clinical trials.},
author = {Zaremba T and Thomas H and Cole M and Plummer ER and Curtin NJ.},
year = {2010},
journal = {Cancer Chemother Pharmacol},
doi = {10.1007/s00280-010-1359-0},
url = {https://doi.org/10.1007/s00280-010-1359-0}
}RIS
TY - JOUR TI - Doxorubicin-induced suppression of poly(ADP-ribose) polymerase-1 (PARP-1) activity and expression and its implication for PARP inhibitors in clinical trials. AU - Zaremba T AU - Thomas H AU - Cole M AU - Plummer ER AU - Curtin NJ. PY - 2010 JO - Cancer Chemother Pharmacol DO - 10.1007/s00280-010-1359-0 UR - https://doi.org/10.1007/s00280-010-1359-0 ER -
APA
T, Z., H, T., M, C., ER, P., & NJ., C. (2010). Doxorubicin-induced suppression of poly(ADP-ribose) polymerase-1 (PARP-1) activity and expression and its implication for PARP inhibitors in clinical trials.. Cancer Chemother Pharmacol. https://doi.org/10.1007/s00280-010-1359-0
Source records
- europe-pmc · retrieved 2026-09-25T13:12:33.275Z
- hal · retrieved 2026-09-25T13:12:33.325Z